Concepedia

Yuening Sun

YS

Statistics

Publications

10

Citations

549

H-Index

10

Active since

2019

Affiliations

State Key Laboratory of Natural Medicine(Current)

China Pharmaceutical University

Guangzhou Medical University

Guangzhou First People's Hospital

Guangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality

Yuening Sun is an author at State Key Laboratory of Natural Medicine specializing in molecular oncology, oncology, and cancer biology.

ORCID

Publications per year

2019–2024

10

Publications

10

CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma

Jingyue Yao, Jubo Wang, Ye Xu et al. · Autophagy · 2021 · 258 citations · Full text

, , +14

Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma

Liling Jiang, Yuening Sun, Jinxiang Wang et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 53 citations · Full text

, , +12

Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling

Jingyue Yao, Shu Xu, Yuening Sun et al. · Acta Pharmacologica Sinica · 2021 · 52 citations · Full text

, , +15

USP7 promotes non‐small‐cell lung cancer cell glycolysis and survival by stabilizing and activating c‐Abl

Yuanming He, Shuoyi Jiang, Yueya Zhong et al. · Clinical and Translational Medicine · 2023 · 50 citations · Full text

, , +13

Apoptosis induction in human prostate cancer cells related to the fatty acid metabolism by wogonin-mediated regulation of the AKT-SREBP1-FASN signaling network

Yuening Sun, Wenjing Guo, Yongjian Guo et al. · Food and Chemical Toxicology · 2022 · 30 citations

, , +17

1–5 of 10